Clinical Trial

Pistacia Lentiscus Oil Nasal Drops for Preventing Recurrence of Chronic Rhinosinusitis

Completed
View on ClinicalTrials.gov →
Summary
This retrospective, observational, case-control clinical study evaluated the safety and efficacy of nasal drops containing Pistacia lentiscus oil in preventing recurrence of chronic rhinosinusitis during long-term therapy. Adult patients with chronic rhinosinusitis who received isotonic saline wash plus Pistacia lentiscus oil drops were retrospectively compared with patients who received isotonic saline wash alone, with a total treatment duration of 12 months. The primary outcome was change in Sino-Nasal Outcome Test-22 (SNOT-22) scores, while secondary outcomes included ciliary motility, nasal secretion, biofilm presence, cytological changes, adverse events, and safety/tolerability.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2025-06-18 -> 2025-03-03 2026-05-15
minor Completion moved earlier: 2025-08-30 -> 2025-03-30 2026-05-15
Trial Details
NCT Number NCT07198607
Lead Sponsor Liaquat University of Medical & Health Sciences
Collaborators: Università degli Studi dell'Insubria
Conditions Chronic Rhinosinusitis Without Nasal Polyps, Chronic Rhinosinusitis (Diagnosis)
Enrollment 100 participants
Start Date 2023-04-04
Primary Completion 2025-03-03 (estimated)
Study Completion 2025-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-14